China Sky One's Leaders Aim To Derail Potential Shareholders' Suit Headed By California Law Firm
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Just weeks after alleging that U.S. media reports constituted "reckless criticism and attacks" for suggesting that China Sky One Medical misreported earnings, the Chinese firm has now confirmed that it filed inaccurate revenue statements with Chinese commercial authorities